Keith Fay

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy

Timothy P. Hughes, Susan Branford, Deborah L. White et al. · Blood · 2008 · 177 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +10

Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy

Joerg Halter, W. Michael, Michaël Schüpbach et al. · Brain · 2015 · 142 citations · Full text

Medicine, Hematology, Neurology +16

Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach

Jörg Halter, Michaël Schüpbach, Carlo Casali et al. · Bone Marrow Transplantation · 2010 · 114 citations

Life Sciences, Hematology, Neurology +9

Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors

G. Kumarasinghe, Orly Lavee, Andrew Parker et al. · The Journal of Heart and Lung Transplantation · 2015 · 62 citations · Full text

Medicine, Immunology, Pathology +17